AI-assisted Transcranial Duplex Sonography for Early Detection of Intracerebral Haemorrhage: HYPER-AI-SCAN
NCT ID: NCT07319013
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2025-03-14
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
Is it feasible to perform standardized protocol transcranial ultrasound in acute stroke patients? Can AI models trained on ultrasound images accurately distinguish haemorrhagic stroke ("ICH suspected") from non-haemorrhagic stroke? There is no comparison group, because all participants will undergo both CT (as standard care) and ultrasound (research imaging), and the AI models will compare their ultrasound-based predictions against CT-confirmed diagnoses.
Participants will:
undergo a non-invasive transcranial ultrasound scan after CT confirms the type of stroke allow researchers to collect coded ultrasound images for AI model training provide clinical and imaging information (already collected as part of routine care) to help evaluate factors related to diagnostic accuracy No treatments or changes to clinical care will be introduced as part of the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automatic PredICtion of Edema After Stroke
NCT04057690
Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage
NCT07246473
Multimodal Brain Monitoring as a Prognostic Tool for Intracerebral Hemorrhage
NCT05771662
Retrospective Study of Intracerebral Hemorrhage Patients in Hospital Parc Taulí
NCT04877405
Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)
NCT05501613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, the only reliable way to distinguish between these two types of stroke is with a brain scan such as a CT scan. However, CT is not always available immediately, especially in prehospital settings or in hospitals without 24/7 imaging access. As a result, patients may experience delays before receiving the correct treatment.
This study aims to explore whether a simple ultrasound scan of the brain, performed through the skull, can help identify haemorrhagic stroke more quickly. This technique is called transcranial Doppler ultrasound (TCD). It is fast, non-invasive, and uses no radiation.
A total of 500 patients with suspected stroke within 48 hours of symptom onset will be included. After the standard CT scan confirms the diagnosis, each participant will undergo a brief ultrasound scan following a structured protocol.
The ultrasound images will then be used to train and test artificial intelligence (AI) models, which will learn to recognize patterns associated with haemorrhagic stroke. These AI models will compare the ultrasound images with CT results and try to predict whether a bleed is present ("ICH suspected") or not.
The main goals of the study are:
To determine whether portable ultrasound can be performed reliably and consistently in real stroke patients.
To evaluate whether AI can support clinicians by interpreting these ultrasound images and distinguishing between haemorrhagic and non-haemorrhagic strokes.
All other clinical information-such as symptoms, timing of arrival, and medical history-will also be collected to understand which factors may influence the performance of ultrasound and AI.
Importantly, the ultrasound does not replace standard medical care and will not influence the treatment that patients receive. It is performed only for research purposes. The CT scan remains the reference test for diagnosis.
By combining ultrasound with AI, this project hopes to pave the way for future systems capable of assisting paramedics or physicians in identifying haemorrhagic stroke earlier, especially in settings where CT is not immediately available. Earlier recognition may help reduce delays in blood pressure management or treatment reversal for patients taking anticoagulants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute stroke patients
Single cohort of adults with suspected acute stroke (\<48 hours from symptom onset), including both ischaemic and intracerebral haemorrhagic stroke. All participants will undergo standard diagnostic evaluation with computed tomography (CT). A research transcranial Doppler ultrasound (TCD) examination will then be performed using a standardized acquisition protocol. Coded sonographic data will be used to train and evaluate artificial intelligence (AI) models for the classification of intracerebral haemorrhage ("ICH suspected" vs. "No ICH"). No intervention or change in clinical management is introduced as part of the study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of acute stroke (ischemic or intracerebral hemorrhage).
* Able to undergo transtemporal transcranial ultrasound according to the standardized protocol (no clinical instability)
* Informed consent obtained from the patient or legally authorized representative, per local regulations.
Exclusion Criteria
* Isolated subarachnoid hemorrhage without parenchymal involvement.
* Hemodynamic instability or medical conditions requiring immediate life-saving intervention that preclude safe ultrasound recording.
* Known skull defects or prior craniectomy on the side required for contralateral insonation.
* Any condition that, in the opinion of the investigators, would interfere with protocol adherence or data accuracy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitari Vall d'Hebron Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Vall D'Hebron
Barcelona, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Simonetti R, Canals P, Gonzalez Riveros JD, Alanis-Bernal M, Pancorbo O, Rodriguez-Luna D. Feasibility of an AI-assisted transcranial duplex sonography protocol for early detection of intracerebral haemorrhage: the HYPER-AI-SCAN single-centre prospective study. BMJ Open. 2025 Nov 19;15(11):e102903. doi: 10.1136/bmjopen-2025-102903.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR(AG)015/2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.